IMDx

IMDx designs, develops and manufactures platform-agnostic, regulatory-cleared molecular diagnostic tests that enable partners to rapidly and efficiently expand test menus. Beyond growing its portfolio of assays for infectious disease, IMDx is pursuing new targets in companion diagnostics, oncology and human genetics, as well as next generation instrument systems. Mission:?IMDx?s mission is to develop and manufacture superior performing, clinically impactful molecular diagnostic testing solutions. To guarantee quality for customers and partners, we develop and manufacture tests under FDA Quality System Regulations and ISO guidelines. IMDx develops molecular tests for a range of disease areas for current and next generation systems, including targets in infectious diseases, oncology and genetics.